报告从行业事件分析、竞争环境、医药研发、竞争对手、行业数据等几个方面进行了分析评论。

报告从政策环境、市场行情、厂商动态、科技研发、国际资讯、行业数据、分析评论等几个方面进行了分析评论。

报告从政策环境、市场行情、厂商动态、科技研发、国际资讯、行业数据、分析评论等几个方面进行了分析评论。

报告从行业事件分析、竞争环境、医药研发、竞争对手、行业数据等几个方面进行了分析评论。

报告从产业动态、产业分析、技术趋势、企业跟踪、地方动向等几个方面对生物科技产业进行了分析评论。

上半年，在世界经济缓慢复苏，全球医药市场格局变化和我国医药内需发展强劲等内外因素的共同作用下，我国生物药品制造业出口交货值自2013年初扭转上年持续下滑态势之后，始终保持较快增长态势。上半年，我国生物药品制造业出口交货值为104.22亿元，同比增长11.56%，而上年同期为下降4.79%。3季度，宏观经济有望稳中略有回升，国内消费市场总体需求有望好转。预计2013年全年，生物药品制造业将保持良好发展势头，疫苗批签发量将保持快速增长；国外医药景气度将有所回温，生物药品制造业出口交货值将达到207亿元， 同比增长11.7%左右；全年实现销售收入约2412亿元，同比增长17.8%左右；实现利润总额约311亿元，同比增长约22%。

An ostomy is a surgically made opening in the skin that allows for the external excretion of waste products from the intestines (procedure is known as ileostomy or colostomy) or from the bladder (procedure is called urostomy). Ostomy products include ostomy bags/pouches, deodorants, irrigation products, skin barriers, and care products. Incontinence is a medical condition in which a person loses bladder control; in some cases there is an involuntary excretion of bowel contents. Incontinence products, hence, provide physical protection against involuntary urine and bowel leakage. These products can be disposed in a discreet manner and ensure a person is leading an active and social life without facing any embarrassment.The Global Ostomy and Incontinence Products market is growing at a steady rate. The majority of its growth stems from the EMEA region; followed by the Americas and the APAC region. The US, which has the world's highest per capita healthcare expenditure, was leading the Global Ostomy and Incontinence Products market in 2012. The market is expected to witness an improvement in its growth rate and post a CAGR of 5.51 percent during the period 2012-2016.

The Global Orthopedic Bracing and Supports market is growing at a steady rate. The Americas dominated the market, followed by the EMEA region and the APAC region. The US, which has the world's highest per capita healthcare expenditure, was the leading country in the Global Orthopedic Bracing and Supports market in 2012. The market is expected to witness an improvement in its growth rate and is estimated to grow at a CAGR of 4.66 percent during the period 2012-2016.

The Global Parkinson's Disease market is expected to grow at a steady pace during the period 2012-2016. The market was dominated by the Americas in 2012, and was followed by the EMEA and APAC regions. Currently, a major part of the market growth is derived from the Dopamine Agonists segment. Other segments, such as the COMT Inhibitor segment and the Dopamine Replacement Agents segment, are expected to make significant contributions to the revenue of the overall market in the next few years. Factors such as the lack of efficacious products in the market, various patent expirations, and a weak pipeline are expected to limit the growth of the Global Parkinson's Disease market during the forecast period. Currently, the market has limited treatment options and numerous unmet needs in Parkinson's disease treatment. However, new entrants are expected to gain a significant market share during the forecast period as they are developing numerous novel molecules which have the potential to alter the progression of the disease. The Global Parkinson's Disease market is expected to post a CAGR of 1.67 percent during the forecast period.